April 26, 2024
AstraZeneca CEO on US-China tensions: \’We have established a very resilient supply chain\’
AstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company reported $12.7 billion in revenue, beating consensus estimates of $11.8 billion in the first quarter of 2024.